Piper Sandler raised the firm’s price target on Align Technology to $370 from $360 and keeps an Overweight rating on the shares post the Q1 results. With expectations moving higher ahead of the print, with Invisalign case volumes beating only slightly, and with the near-term outlook one of stability rather than improvement, the shares may give up some recent gains today, the analyst tells investors in a research note. However, Piper is encouraged by Align’s near-term revenue and earnings trajectory.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ALGN:
- Align Technology reports Q1 adjusted EPS $1.82, consensus $1.68
- Align Technology options imply 9.0% move in share price post-earnings
- Notable companies reporting after market close
- Align Technology price target raised to $390 from $375 at Stifel
- Early notable gainers among liquid option names on March 31st